Sacral neuromodulation test with bilateral first stage tined lead procedure in patients with non-obstructive urinary retention: A pilot study
Completed
- Conditions
- 10004994retentionurinary retention bladder
- Registration Number
- NL-OMON33635
- Lead Sponsor
- rologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
Patients (male and female), aged between 18-70 years, with urinary retention or voiding dysfunction, such as hesitancy or intermittency, that are due to an acontractile detrusor or to urethral sphincter dysfunction. The overactivity of the sphincter may occur in absence of detrusor contraction and may be the cause of the lack of detrusor activity
Exclusion Criteria
Known neurologic disease or impairment including DM (severe or uncontrolled diabetes; or diabetes with peripheral nerve involvement), spinal cord injury, MS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is the eligibility for SNM therapy. This is defined as yes<br /><br>or no. A patient is eligible for the therapy when he or she can void again or<br /><br>the volume increased with at least 50%, and the catheterized volume is less<br /><br>then 100ml. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Average voided volume and average catheterized volume</p><br>